Artificial intelligence systems can now convince you they are human. Two large language models have passed the Turing test, which determines if a machine can “show the same intelligence as a human ...

Recurrent neural networks were proven to be Turing universal in the 1990s, motivating computational complexity studies of spiking networks, neural Turing machines with differentiable activations, and ...

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Before the 1990s, most safety precautions were handled by external hardware such as contactors, relays, and switches. Emergency stops were used to physically remove power from drives and controllers.

Computing power has come a long way since mathematician Alan Turing broke the Nazi’s Enigma machine code. Even so, the Father of AI saw what the possibilities were way back in 1951 when he gave a ...

Steam washing machines from brands like LG, Haier and Samsung are making tough stains, allergens and odours easy to deal with. With deep clean technology built into every cycle so these advanced ...

Alan Turing's radical insight was that any mechanical thought process could be stripped down to a few symbolic operations on a strip of tape. This video unpacks how that elegant simplification became ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...

One afternoon in October 1979, Gilles Brassard was swimming outside a beachfront hotel in San Juan, Puerto Rico, when a stranger swam up to him and changed the course of his career. Without so much as ...

SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

The consensus mark for RXRX's Q4 loss and sales are pinned at 28 cents per share and $25.5M, respectively. In late 2025, RXRX highlighted REC-4881 data showing rapid, durable polyp reductions in FAP ...